Trial reportClinical oral investigations2026
Comparison of injectable platelet-rich fibrin, titanium platelet-rich fibrin, and 0.8% hyaluronic acid applications versus periodontal dressing alone in wound healing after gingivectomy and gingivoplasty operations: randomized controlled clinical study.
Trial report in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe primary objective of this study was to evaluate the effects of injectable platelet-rich fibrin (I-PRF), titanium-prepared platelet-rich fibrin (T-PRF), and 0.8% hyaluronic acid (HA) gel compared with a naturally healing control group on gingival wound healing and epithelialization following gingivectomy and gingivoplasty in plaque-induced gingival enlargement. Secondary objectives were to assess clinical periodontal parameters and patient-reported outcomes during a 28-day follow-up period. MATERIALS AND
methodsThe study included four groups: a control group and three test groups treated with I-PRF, T-PRF, and 0.8% HA gel. All patients underwent gingivectomy and gingivoplasty after the first step of periodontal therapy. Pain and burning were recorded using VAS during the first postoperative week, and analgesic consumption and bleeding were also recorded. Oral health–related quality of life was assessed using OHIP-14. Wound healing was evaluated using Mira-2 Tone staining with digital image analysis, the Landry, Turnbull, and Howley (LTH) wound-healing index, and the H₂O₂ foaming test at days 7, 14, 21, and 28, while clinical periodontal parameters were reassessed at day 28.
resultsA total of 60 systemically healthy patients were included in the study: I-PRF (n = 15), T-PRF (n = 15), 0.8% HA (n = 15), and control (n = 15). Significant intergroup differences were observed in several clinical and wound-healing parameters. At day 28, the HA group showed significantly lower gingival inflammation and bleeding compared with the I-PRF, T-PRF, and control groups (p < 0.05). All intervention groups demonstrated improved wound healing compared with the control group. On day 7, the control group exhibited a significantly larger non-epithelialized area (169,440 ± 23,583) than the HA group (122,262 ± 18,363), representing a mean reduction difference of 47,178. LTH wound-healing scores were significantly higher in the intervention groups than in the control group across all time points (all p ≤ 0.005). Pain, burning, and oral health–related quality of life improved significantly over time in all groups (p < 0.001), with the HA and I-PRF groups reporting lower discomfort scores.
conclusionsI-PRF, T-PRF, and HA enhanced epithelial wound healing and patient comfort compared with control, with HA providing superior reductions in gingival inflammation and bleeding. However, due to the subjective nature of some measures and the lack of histological/molecular analyses, further long-term studies are necessary to confirm these clinical outcomes and understand the underlying biological mechanisms. CLINICAL RELEVANCE: Adjunctive use of HA, I-PRF, and T-PRF may improve soft-tissue healing and patient comfort after gingivectomy. HA may be particularly practical in routine clinical settings because it does not require blood collection or centrifugation. Therefore, the choice of adjunctive treatment may depend on clinical logistics and cost considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.